Venus Versa Gets FDA Clearance for 20+ Clinical Indications


We are excited to announce today the Venus Versa™, a multi-application device intended to be used in aesthetic and cosmetic procedures, has received FDA clearance for use in the treatment of 20 clinical indications.

Aesthetic professionals across the U.S. can now effectively treat more than twenty in-demand treatments in a safe and non-invasive manner, such as skin rejuvenation, hair removal, facial wrinkles and rhytides, skin resurfacing, pigmented and vascular lesions, and acne vulgaris.

Venus Versa™ is the first and only platform to combine Intense Pulse Light, SmartPulse technology, Multi-Polar Radio Frequency, Pulsed Electro Magnetic Fields, and Nano-Fractional Radio Frequency via SmartScan technology to tackle some of the most in-demand aesthetic procedures requested by patients worldwide today. Its breakthrough cooling technology, precise and consistent energy delivery, and fast treatment cycles results in the best patient experience available in the market.

“We are excited that Venus Versa is now available to physicians and aesthetic professionals looking for a cost-effective alternative to treat more than 20 clinical indications in one single platform,” said Domenic Serafino, Chairman and Chief Executive Officer at Venus Concept. “This launch reinforces Venus Concept’s commitment to developing technology that addresses the current needs of aesthetic professionals and their patients.”

Venus Versa™ is safe for all skin types, with no pain or downtime. Unlike surgical alternatives, the Venus Versa™ is able to provide the benefits of smoother, clearer, more youthful skin without having to go through anaesthesia, incisions, or any recovery time.

Learn more about the Venus Versa™ or book a demo of this revolutionary device today.

Interested in learning more about Venus Concept devices and treatments?